Skip to main content
Skip to main content

AAP Gateway

Advanced Search »

User menu

  • Login
  • Current Policy
  • Topic/Program Collections
  • Submit Manuscript
  • Alerts
  • Subscribe
  • aap.org

Menu

  • AAP Grand Rounds
  • AAP News
  • Hospital Pediatrics
  • NeoReviews
  • Pediatrics
  • Pediatrics in Review
  • Current AAP Policy
  • Journal CME
  • AAP Career Center
  • Pediatric Collections
  • AAP Journals Catalog

Sections

    • Login
    • Current Policy
    • Topic/Program Collections
    • Submit Manuscript
    • Alerts
    • Subscribe
    • aap.org

    Sign up for Insight Alerts highlighting editor-chosen studies with the greatest impact on clinical care.

    New! Video Abstracts -- brief videos summarizing key findings of new articles

    Know what's next when you read AAP Journals, view the new 2018 Catalog.
    Trainees,
    enter the SOPT Essay Contest for a chance to be published in Pediatrics!

    Advertising Disclaimer »

    Tools and Links

    Pediatrics
    April 2018, VOLUME 141 / ISSUE Supplement 5
    From the American Academy of Pediatrics
    Case Report

    Craniosynostosis as the Presenting Feature of X-linked Hypophosphatemic Rickets

    Janaki D. Vakharia, Kristal Matlock, Helena O. Taylor, Philippe F. Backeljauw, Lisa Swartz Topor
    • Article
    • Figures & Data
    • Info & Metrics
    • Comments
    Loading
    Download PDF

    Abstract

    Craniosynostosis is the premature closure of cranial sutures. Primary, or congenital, craniosynostosis is often sporadic but may be associated with genetic or chromosomal abnormalities. Secondary craniosynostosis presents after gestation, and can occur in metabolic bone diseases, including rickets. We describe the first reported cases of primary craniosynostosis in 2 unrelated, term infants with X-linked hypophosphatemic rickets (XLH). The diagnosis of XLH in both patients was confirmed by genetic testing. At the time craniosynostosis was detected, the patient in the first case did not have any other clinical features of XLH. The second patient developed clinical findings of craniosynostosis, followed by rickets. These are the earliest reported cases of craniosynostosis in XLH and demonstrate that craniosynostosis may be a presenting feature of this disease.

  • Abbreviations:
    FGF23 —
    fibroblast growth factor 23
    PHEX —
    phosphate regulating endopeptidase homolog X-linked
    PTH —
    parathyroid hormone
    XLH —
    X-linked hypophosphatemic rickets
  • Background

    X-linked hypophosphatemic rickets (XLH), the most common hereditary form of hypophosphatemic rickets, is caused by a loss of function mutation of the phosphate regulating endopeptidase homolog X-linked (PHEX) gene.1 Children affected by XLH typically have low serum phosphorus and inappropriately high urine phosphorus due to renal phosphorus wasting. Alkaline phosphatase is most often elevated, and vitamin D, serum calcium, and parathyroid hormone (PTH) levels are usually normal. Lower extremity bowing and impaired linear growth typically do not occur until the child is weight bearing. Because most children with hypophosphatemia are asymptomatic in infancy, those ultimately diagnosed with XLH typically do not come to the attention of medical providers until skeletal deformities and poor growth become apparent. The severity of patients’ clinical presentation is variable and can vary among family members with the same genetic mutation.1 Dental abnormalities, related to poor mineralization and dysplasia of dentin, and enthesopathy due to abnormal calcification of tendons, joint capsules, and/or ligaments may also develop in XLH patients, although usually later in life.1,2

    Craniosynostosis, the premature closure of cranial sutures, has been reported in patients with XLH. Craniosynostosis causes head shape deformity, and may, in a subset of patients, lead to increased intracranial pressure, ophthalmologic problems, and developmental delay. Primary or congenital craniosynostosis is typically diagnosed in infancy and may be isolated and sporadic, or, more rarely, is associated with specific genetic syndromes.3 Craniosynostosis secondary to underlying metabolic bone disease, including all forms of rickets, is less common and usually develops postnatally, much later than craniosynostosis caused by nonmetabolic disorders.4–7 We describe the first reported cases of primary craniosynostosis as the presenting feature of XLH diagnosed in early infancy.

    Case 1

    A term female infant was born with an abnormally long cranium. At 3 months of age, she was diagnosed with scaphocephaly secondary to isolated sagittal synostosis, confirmed by a three-dimensional computerized tomography scan (Fig 1). Family history was notable for XLH due to a mutation in the PHEX gene (c.832G>A; p.Glu278Lys) in her mother, maternal grandmother, and maternal cousins. The mother was treated with phosphate and calcitriol and was otherwise healthy. Leading up to the patient’s diagnosis of craniosynostosis, she had normal growth and no features of rickets. At the age of 1 month, her serum phosphorus and calcium were normal. Results from repeat laboratory studies around 3 months of age showed low phosphorus and increased alkaline phosphatase, but normal serum calcium, PTH, 25- hydroxyvitamin D, and urine calcium. Urine phosphorus was 3 mg/dL (Table 1). The patient was referred for a pediatric endocrine evaluation, and based on the serum and urine laboratory test results in the setting of the family history, she was diagnosed with XLH. Treatment with phosphate and calcitriol was initiated. Results from subsequent genetic testing confirmed the XLH diagnosis, which identified the same PHEX mutation as found in her mother. According to our preferred institutional protocol, the patient had cranial vault remodeling at 5.5 months without complication (Fig 2). At 10 months of age, she was noted to have mild lower extremity bowing, which improved with continued treatment with phosphorous and calcitriol. At 2.5 years of age, the patient no longer had bowing of the lower extremities. Growth continued along the 30th to 45th percentiles, and at age 2.5 years, height z score was −0.47 SD.

    FIGURE 1
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 1

    Primary sagittal synostosis in an infant (Case 1) with XLH. A, The entirely fused sagittal suture (arrow), anterior fontanelle, and open coronal (C) and metopic (M) sutures. B, The classic sagittal view of scaphocephaly and open coronal, lambdoid, (L) and squamosal sutures (S).

    View this table:
    • View inline
    • View popup
    TABLE 1

    Laboratory Values Before and at the Time of the Diagnosis of Craniosynostosis

    FIGURE 2
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 2

    A, A preoperative photograph of Case 1. Classic scaphocephaly is seen. B, A photograph of postcranial vault reconstruction.

    Case 2

    An otherwise healthy term male infant with frontal bossing at birth was noted to have sagittal ridging at 3 months of age and protruding left occiput (or occipital “bullet deformity”) by 6 months of age. Skull radiographs showed diffuse calvarial thickening. A three-dimensional computerized tomography of the head revealed partial fusion of the sagittal suture with scaphocephaly and coarse trabecular thickening of the medullary cavity of the skull base, maxilla, and mandible. Linear growth, weight gain, development, and family history were normal. Laboratory evaluation showed low phosphorus, increased alkaline phosphatase, normal calcium, magnesium, 25- and 1,25-(di)hydroxyvitamin D, PTH, and renal function, but low tubular reabsorption of urine phosphorus, consistent with renal phosphate wasting (Table 1). A skeletal survey showed rickets changes. Results from genetic testing revealed a mutation in the PHEX gene (c.2198G>C; p.Cys733Ser), confirming XLH as the diagnosis. Phosphate and calcitriol supplementation was initiated and at 2 years of age the lower extremity bowing has nearly resolved. Current height is between the 10th to 25th percentiles (height z score: −1.23 SD). Without developmental delay and only relatively mild scaphocephaly, the patient did not undergo surgical correction.

    Discussion

    We describe 2 patients who were diagnosed with congenital sagittal craniosynostosis in early infancy, before any other signs of rickets developed and before the diagnosis and initiation of treatment of XLH. Although multiple reports have described secondary craniosynostosis in older children with XLH, congenital craniosynostosis as a presenting feature of XLH in children <1 year old has not been described. In a case series of 3 children with XLH and craniosynostosis, authors described 1 boy with a scaphocephalic head shape from birth, which suggested early development of craniosynostosis, but evaluation for and diagnosis of sagittal synostosis did not occur until he was 2 years old.8 In our 2 cases, we suggest expansion of the previously described time line of craniosynostosis development in children with XLH.

    In a retrospective study, Seruya et al7 assessed the age of initial craniofacial evaluation in 211 children with craniosynostosis due to a variety of etiologies. In the entire cohort, the median age of presentation with craniosynostosis was 4.1 months. Patients with syndromes associated with craniosynostosis and those without syndromes presented at similar median ages of 4.0 to 4.1 months. In contrast, the 3 patients with XLH in that study presented at a much later median age (32.3 months).7 In one study of 59 children with different forms of rickets, the authors identified 16 children with craniosynostosis who were diagnosed at a median age of 45.6 months.6 In another study, the authors looked at 10 children with hypophosphatemic rickets, 5 of which had XLH, and described the evaluation of craniosynostosis in those with XLH ranging from 13 months to 5 years, with the median age of 24 months.5

    The development of craniosynostosis in general, and particularly in XLH, is not fully understood, and a variety of mechanisms have been proposed. Elevated concentrations of fibroblast growth factor 23 (FGF23) due to the loss of function mutation in the PHEX gene has been thought to lead to the deregulation of phosphate and vitamin D metabolism in patients with XLH.5,9 Interaction of FGF23 with FGF receptors 2 and 3 along cranial sutures has also been hypothesized as a mechanism of developing secondary craniosynostosis.10,11 Additionally, in mouse models, PHEX interacts with a matrix extracellular phosphoglycoprotein, which inhibits bone mineralization.12 Abnormal phosphate metabolism and inhibition of bone mineralization both have the potential to contribute to craniosynostosis. Vitamin D toxicity has previously also been suggested as a contributing factor in craniosynostosis development, and authors of 1 report described a 14-month old boy with XLH who developed craniosynostosis after 6 months of treatment with 1-α -cholecalciferol. The boy had symptoms of vitamin D toxicity, including anorexia, irritability, and failure to thrive, and was diagnosed with scaphocephaly and increased intracranial pressure.13 However, vitamin D is unlikely to be the only factor in development of craniosynostosis in children with XLH because many other cases of craniosynostosis develop in children without laboratory or clinical evidence of vitamin D toxicity.6,8,10,14

    Proposed mechanisms contributing to primary craniosynostosis include in utero fetal head constraint,15,16 prenatal exposures to valproic acid, maternal hyperthyroidism,4 and several genetic mutations.17 Mutations associated with syndromic craniosynostosis include twist homolog 1, fibroblast growth factor receptor 2, fibroblast growth factor receptor 3, and ephrin-B1.3,17,18 Mutations in twist homolog 1 are the cause of Saethre Chotzen syndrome, whereas fibroblast growth factor receptor mutations cause Pfieffer and Crouzon syndromes, and mutations in ephrin-B1 cause craniofrontonasal dysplasia. These syndromes are often associated with bicoronal synostosis and midface anomalies, which were not found in our patients. Because genetic testing has not been shown to be helpful in cases of isolated sagittal suture synostosis,19 additional testing was not performed in our patients. In contrast, genetic testing is often performed for bicoronal or multisuture synostosis or craniosynostosis with other phenotypic features.17,18,20 Treatment, including surgery to allow for cranial expansion and normalization of head shape, and may be performed via strip craniectomy or open cranial vault remodeling, which is largely dependent on institutional preference.

    To date, an association between congenital craniosynostosis and rickets has not been described. Previous reports on children with rickets suggest monitoring for skull changes once the rickets diagnosis is made,7,21 which often occurs after infancy. Our patients show that craniosynostosis can present early in life, before any other symptoms or treatment of rickets. We now suggest that screening for XLH and other forms of hypophosphatemic rickets could be included in the evaluation of primary or congenital craniosynostosis in patients with either a family history and/or clinical features of rickets. Initial tests may include serum alkaline phosphatase and phosphorous as well as urine phosphorous. These tests are a cost-effective method for the initial evaluation of primary craniosynostosis in patients with a family history of bone mineralization diseases or those with evidence of rickets. We also recommend surveillance for skull shape abnormalities by careful physical examination in all children at the time of diagnosis of XLH or other forms of rickets and repeated over time. We recommend that this monitoring is extended to infants and children who are at risk for familial forms of rickets.

    Conclusions

    Our patients presented with craniosynostosis as the initial manifestation of XLH. Initial signs of craniosynostosis were present at or soon after birth, in the absence of intrauterine risk factors or prenatal exposures, and before any treatment of XLH was instituted. To our knowledge, these are the first reported cases of primary craniosynostosis in XLH and reveal that craniosynostosis may be a presenting feature of XLH. We recommend that the evaluation of primary craniosynostosis include consideration of XLH and other forms of hypophosphatemic rickets.

    Footnotes

      • Accepted December 18, 2017.
    • Address correspondence to Lisa Swartz Topor, MD, MMSc, Division of Pediatric Endocrinology, Rhode Island Hospital/The Warren Alpert Medical School of Brown University, 593 Eddy St, Providence, RI 02903. E-mail: lisa_swartz_topor{at}brown.edu
    • FINANCIAL DISCLOSURE: The authors have indicated they have no financial relationships relevant to this article to disclose.

    • FUNDING: No external funding.

    • POTENTIAL CONFLICT OF INTEREST: The authors have indicated they have no potential conflicts of interest to disclose.

    References

    1. ↵
      1. Capelli S,
      2. Donghi V,
      3. Maruca K, et al
      . Clinical and molecular heterogeneity in a large series of patients with hypophosphatemic rickets. Bone. 2015;79:143–149pmid:26051471
      OpenUrlPubMed
    2. ↵
      1. Pereira CM,
      2. de Andrade CR,
      3. Vargas PA,
      4. Coletta RD,
      5. de Almeida OP,
      6. Lopes MA
      . Dental alterations associated with X-linked hypophosphatemic rickets. J Endod. 2004;30(4):241–245pmid:15085056
      OpenUrlCrossRefPubMedWeb of Science
    3. ↵
      1. Wilkie AO,
      2. Byren JC,
      3. Hurst JA, et al
      . Prevalence and complications of single-gene and chromosomal disorders in craniosynostosis. Pediatrics. 2010;126(2). Available at: www.pediatrics.org/cgi/content/full/126/2/e391pmid:20643727
      OpenUrlAbstract/FREE Full Text
    4. ↵
      1. Cohen MM Jr
      . Etiopathogenesis of craniosynostosis. Neurosurg Clin N Am. 1991;2(3):507–513pmid:1821298
      OpenUrlPubMed
    5. ↵
      1. Vega RA,
      2. Opalak C,
      3. Harshbarger RJ, et al
      . Hypophosphatemic rickets and craniosynostosis: a multicenter case series. J Neurosurg Pediatr. 2016;17(6):694–700pmid:26824597
      OpenUrlPubMed
    6. ↵
      1. Reilly BJ,
      2. Leeming JM,
      3. Fraser D
      . Craniosynostosis in the rachitic spectrum. J Pediatr. 1964;64:396–405pmid:14130713
      OpenUrlCrossRefPubMedWeb of Science
    7. ↵
      1. Seruya M,
      2. Oh AK,
      3. Boyajian MJ, et al
      . Age at initial consultation for craniosynostosis: comparison across different patient characteristics. J Craniofac Surg. 2013;24(1):96–98pmid:23348263
      OpenUrlPubMed
    8. ↵
      1. Jaszczuk P,
      2. Rogers GF,
      3. Guzman R,
      4. Proctor MR
      . X-linked hypophosphatemic rickets and sagittal craniosynostosis: three patients requiring operative cranial expansion: case series and literature review. Childs Nerv Syst. 2016;32(5):887–891
      OpenUrl
    9. ↵
      1. Jonsson KB,
      2. Zahradnik R,
      3. Larsson T, et al
      . Fibroblast growth factor 23 in oncogenic osteomalacia and X-linked hypophosphatemia. N Engl J Med. 2003;348(17):1656–1663pmid:12711740
      OpenUrlCrossRefPubMedWeb of Science
    10. ↵
      1. Murthy AS
      . X-linked hypophosphatemic rickets and craniosynostosis. J Craniofac Surg. 2009;20(2):439–442pmid:19242361
      OpenUrlCrossRefPubMed
    11. ↵
      1. Ishii M,
      2. Sun J,
      3. Ting MC,
      4. Maxson RE
      . The development of the calvarial bones and sutures and the pathophysiology of craniosynostosis. Curr Top Dev Biol. 2015;115:131–156pmid:26589924
      OpenUrlCrossRefPubMed
    12. ↵
      1. Rowe PS,
      2. Garrett IR,
      3. Schwarz PM, et al
      . Surface plasmon resonance (SPR) confirms that MEPE binds to PHEX via the MEPE-ASARM motif: a model for impaired mineralization in X-linked rickets (HYP). Bone. 2005;36(1):33–46pmid:15664000
      OpenUrlCrossRefPubMed
    13. ↵
      1. Carlsen NL,
      2. Krasilnikoff PA,
      3. Eiken M
      . Premature cranial synostosis in X-linked hypophosphatemic rickets: possible precipitation by 1-alpha-OH-cholecalciferol intoxication. Acta Paediatr Scand. 1984;73(1):149–154pmid:6538374
      OpenUrlPubMed
    14. ↵
      1. Willis FR,
      2. Beattie TJ
      . Craniosynostosis in X-linked hypophosphataemic rickets. J Paediatr Child Health. 1997;33(1):78–79pmid:9069051
      OpenUrlPubMed
    15. ↵
      1. Twigg SR,
      2. Wilkie AO
      . A genetic-pathophysiological framework for craniosynostosis. Am J Hum Genet. 2015;97(3):359–377pmid:26340332
      OpenUrlCrossRefPubMed
    16. ↵
      1. Herring SW
      . Mechanical influences on suture development and patency. Front Oral Biol. 2008;12:41–56pmid:18391494
      OpenUrlCrossRefPubMed
    17. ↵
      1. Johnson D,
      2. Wilkie AO
      . Craniosynostosis. Eur J Hum Genet. 2011;19(4):369–376pmid:21248745
      OpenUrlCrossRefPubMed
    18. ↵
      1. Lattanzi W,
      2. Bukvic N,
      3. Barba M, et al
      . Genetic basis of single-suture synostoses: genes, chromosomes and clinical implications. Childs Nerv Syst. 2012;28(9):1301–1310
      OpenUrlCrossRefPubMed
    19. ↵
      1. Ye X,
      2. Guilmatre A,
      3. Reva B, et al
      . Mutation screening of candidate genes in patients with nonsyndromic sagittal craniosynostosis. Plast Reconstr Surg. 2016;137(3):952–961pmid:26910679
      OpenUrlPubMed
    20. ↵
      1. Boyadjiev SA; International Craniosynostosis Consortium
      . Genetic analysis of non-syndromic craniosynostosis. Orthod Craniofac Res. 2007;10(3):129–137pmid:17651129
      OpenUrlCrossRefPubMedWeb of Science
    21. ↵
      1. Currarino G
      . Sagittal synostosis in X-linked hypophosphatemic rickets and related diseases. Pediatr Radiol. 2007;37(8):805–812pmid:17551721
      OpenUrlCrossRefPubMed
    • Copyright © 2018 by the American Academy of Pediatrics
    View Abstract
    PreviousNext

     

    Advertising Disclaimer »

    View this article with LENS
    PreviousNext
    Email

    Thank you for your interest in spreading the word on Pediatrics.

    NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

    Enter multiple addresses on separate lines or separate them with commas.
    Craniosynostosis as the Presenting Feature of X-linked Hypophosphatemic Rickets
    (Your Name) has sent you a message from Pediatrics
    (Your Name) thought you would like to see the Pediatrics web site.

    Alerts
    Sign In to Email Alerts with your Email Address
    Citation Tools
    Craniosynostosis as the Presenting Feature of X-linked Hypophosphatemic Rickets
    Janaki D. Vakharia, Kristal Matlock, Helena O. Taylor, Philippe F. Backeljauw, Lisa Swartz Topor
    Pediatrics Apr 2018, 141 (Supplement 5) S515-S519; DOI: 10.1542/peds.2017-2522

    Citation Manager Formats

    • BibTeX
    • Bookends
    • EasyBib
    • EndNote (tagged)
    • EndNote 8 (xml)
    • Medlars
    • Mendeley
    • Papers
    • RefWorks Tagged
    • Ref Manager
    • RIS
    • Zotero
    Share
    Craniosynostosis as the Presenting Feature of X-linked Hypophosphatemic Rickets
    Janaki D. Vakharia, Kristal Matlock, Helena O. Taylor, Philippe F. Backeljauw, Lisa Swartz Topor
    Pediatrics Apr 2018, 141 (Supplement 5) S515-S519; DOI: 10.1542/peds.2017-2522
    del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Connotea logo Facebook logo Google logo Mendeley logo
    Print
    PDF
    Insight Alerts
    • Table of Contents
    • Current Policy
    • Early Release
    • Current Issue
    • Past Issues
    • Editorial Board
    • Editorial Policies
    • Overview
    • Open Access
    • Pediatric Collections
    • Video Abstracts
    • Author Guidelines
    • Reviewer Guidelines
    • Submit My Manuscript

    Subjects

    • Endocrinology
      • Metabolic Disorders
      • Endocrinology
    Back to top

                

    Copyright (c) 2018 by American Academy of Pediatrics

    International Access »           

    Terms of Use
    Privacy Statement
    FAQ

    AAP Pediatrics